EcoDrugPlus

Monoamine Oxidase B

Ensembl ID : ENSMSIG00000007452
Gene Symbol: MAOB
1 Cross references
344 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSMSIG00000013258
Gene Symbol: MGLL
1 Cross references
223 Possible Orthologues:

Myeloid Cell Leukemia Sequence 1

Ensembl ID : ENSMSIG00000006604
Gene Symbol: MCL1
1 Cross references
252 Possible Orthologues:

Myeloperoxidase

Ensembl ID : ENSMSIG00000026179
Gene Symbol: MPO
1 Cross references
196 Possible Orthologues:

Myeloproliferative Leukemia Virus Oncogene

Ensembl ID : ENSMSIG00000016222
Gene Symbol: MPL
1 Cross references
201 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSMSIG00000000933
Gene Symbol: NPR1
1 Cross references
199 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSMSIG00000019296
Gene Symbol: NPR2
1 Cross references
274 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSMSIG00000014110
Gene Symbol: NPR3
1 Cross references
226 Possible Orthologues:

Neuropeptide Y Receptor Y4

Ensembl ID : ENSMSIG00000013881
Gene Symbol: NPY4R
1 Cross references
131 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSMSIG00000031070
Gene Symbol: NPY5R
1 Cross references
150 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSMSIG00000017500
Gene Symbol: NTSR1
1 Cross references
226 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 1

Ensembl ID : ENSMSIG00000022497
Gene Symbol: NTRK1
1 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).